Follow-The-Filings

RPRX · Royalty Pharma PLC

Q2 2026 13F holders

← latest ownership dossier

Ticker
RPRX
Type
Equity
Class
SHS CLASS A
Total reported value ($000, long equity)
Manager Report date Value Shares